LSB INDUSTRIES INC (LXU)

US5021601043 - Common Stock

9.22  +0.2 (+2.22%)

After market: 9.22 0 (0%)

Fundamental Rating

4

Overall LXU gets a fundamental rating of 4 out of 10. We evaluated LXU against 84 industry peers in the Chemicals industry. LXU has only an average score on both its financial health and profitability. LXU is valued expensive and it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

LXU had positive earnings in the past year.
LXU had a positive operating cash flow in the past year.
In multiple years LXU reported negative net income over the last 5 years.
Of the past 5 years LXU 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of 1.40%, LXU perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
The Return On Equity of LXU (3.41%) is comparable to the rest of the industry.
LXU's Return On Invested Capital of 2.34% is on the low side compared to the rest of the industry. LXU is outperformed by 64.29% of its industry peers.
LXU had an Average Return On Invested Capital over the past 3 years of 10.50%. This is above the industry average of 7.00%.
The last Return On Invested Capital (2.34%) for LXU is well below the 3 year average (10.50%), which needs to be investigated, but indicates that LXU had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.4%
ROE 3.41%
ROIC 2.34%
ROA(3y)-0.42%
ROA(5y)-3.91%
ROE(3y)0.75%
ROE(5y)-8.26%
ROIC(3y)10.5%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 3.20%, LXU is in line with its industry, outperforming 45.24% of the companies in the same industry.
With a Operating Margin value of 5.86%, LXU is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
Looking at the Gross Margin, with a value of 12.15%, LXU is doing worse than 79.76% of the companies in the same industry.
LXU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.86%
PM (TTM) 3.2%
GM 12.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.26%
GM growth 5Y28.31%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LXU is still creating some value.
Compared to 1 year ago, LXU has less shares outstanding
LXU has more shares outstanding than it did 5 years ago.
LXU has a better debt/assets ratio than last year.

2.2 Solvency

LXU has an Altman-Z score of 1.58. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LXU (1.58) is worse than 63.10% of its industry peers.
The Debt to FCF ratio of LXU is 15.99, which is on the high side as it means it would take LXU, 15.99 years of fcf income to pay off all of its debts.
LXU's Debt to FCF ratio of 15.99 is in line compared to the rest of the industry. LXU outperforms 50.00% of its industry peers.
LXU has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of LXU (1.07) is worse than 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.99
Altman-Z 1.58
ROIC/WACC0.29
WACC8.16%

2.3 Liquidity

LXU has a Current Ratio of 3.64. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
LXU has a better Current ratio (3.64) than 84.52% of its industry peers.
A Quick Ratio of 3.44 indicates that LXU has no problem at all paying its short term obligations.
LXU has a better Quick ratio (3.44) than 89.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.44

3

3. Growth

3.1 Past

The earnings per share for LXU have decreased strongly by -86.94% in the last year.
Looking at the last year, LXU shows a very negative growth in Revenue. The Revenue has decreased by -37.65% in the last year.
The Revenue has been growing by 9.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-86.94%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-42.86%
Revenue 1Y (TTM)-37.65%
Revenue growth 3Y19.11%
Revenue growth 5Y9.44%
Revenue growth Q2Q-23.63%

3.2 Future

Based on estimates for the next years, LXU will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.03% on average per year.
LXU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.94% yearly.
EPS Next Y-23.45%
EPS Next 2Y2.46%
EPS Next 3Y11.03%
EPS Next 5YN/A
Revenue Next Year-11.06%
Revenue Next 2Y-3.37%
Revenue Next 3Y-1.19%
Revenue Next 5Y4.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.79, which means the current valuation is very expensive for LXU.
Compared to the rest of the industry, the Price/Earnings ratio of LXU is on the same level as its industry peers.
LXU is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.83, which is the current average of the S&P500 Index.
LXU is valuated rather expensively with a Price/Forward Earnings ratio of 23.11.
LXU's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of LXU to the average of the S&P500 Index (20.47), we can say LXU is valued inline with the index average.
Industry RankSector Rank
PE 31.79
Fwd PE 23.11

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LXU is valued cheaper than 80.95% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LXU is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.88
EV/EBITDA 7.83

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.46%
EPS Next 3Y11.03%

0

5. Dividend

5.1 Amount

LXU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LSB INDUSTRIES INC

NYSE:LXU (5/16/2024, 7:04:00 PM)

After market: 9.22 0 (0%)

9.22

+0.2 (+2.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap659.60M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 31.79
Fwd PE 23.11
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.4%
ROE 3.41%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.86%
PM (TTM) 3.2%
GM 12.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.64
Quick Ratio 3.44
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-86.94%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-23.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-37.65%
Revenue growth 3Y19.11%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y